Novo Tellus Capital Partners

What Novo Tellus Capital Partners does

Novo Tellus Capital Partners is a Singapore-based private equity firm founded in 2011 by Wai San Loke, specialising in control buyout and growth investments in mid-market technology and industrials companies across Southeast Asia and the broader Indo-Pacific region. The firm positions itself as a sector specialist within the global supply chain, with explicit coverage across semiconductors, capital equipment, test and assembly, precision manufacturing, industrial automation, advanced materials, software, life sciences, medical devices, healthcare IT, clean energy, and digital services. Its second Southeast Asia fund closed at $250 million in January 2021, and the firm has executed investments including a $40 million commitment to India's Tessolve, controlling stakes in Singapore-based SP Manufacturing and Grand Venture Technology, a divisional carveout of TDConnex from Hong Kong-listed Tongda Group, and a co-investment in U.S.-based MEMS foundry Atomica Corp.

Name

Novo Tellus Capital Partners

Legal name

Novo Tellus Capital Partners Pte Ltd

Website

https://novotellus.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Novo Tellus Capital Partners is a Singapore-based private equity firm founded in 2011 that invests in mid-market technology and industrials companies across Southeast Asia and the Indo-Pacific, deploying proprietary deal flow sourced through sector-specialist networks.

Ownership category

akta.pro rank

Product category

Private Equity Fund Management

NAICS

Other Investment Pools and Funds (5259)

SIC

Investors, Nec (6799)

akta.pro primary industry

Multi-Sector / Generalist Growth Equity (FSANACAO)

Keywords

• Private equity investments
• Mid-market buyouts
• Technology industrials
• Growth equity capital
• Southeast Asia investing

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Fund Management: Novo Tellus generates revenue through traditional private equity fund management structures, including management fees (typically charged as a percentage of committed capital under management) and carried interest (performance fees from successful exits). The firm operates multiple funds including a second Southeast Asia fund closed at $250 million in January 2021.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Novo Tellus Capital Partners is a Singapore-based private equity firm that raises capital from institutional Limited Partners and invests it as control buyout, growth equity, divisional carveout, and management buyout capital into mid-market technology and industrials companies across Southeast Asia and the Indo-Pacific region. The firm manages Southeast Asia-focused funds (with its second fund closed at $250 million in January 2021) and generates returns through portfolio company value creation and exits, exemplified by the nearly 3x return on the Grand Venture Technology exit in October 2025.

Product overview

Novo Tellus Capital Partners is a private equity firm offering investment management services rather than a traditional SaaS product. The firm provides growth equity investment, divisional carve-outs, management buyouts, and strategic capital partnerships to technology and industrials companies in the Indo-Pacific region. The firm manages an active portfolio of companies including Amsino Medical Group, ISDN Holdings, Sunningdale Tech, Atomica, Novoflex, TDConnex, Grand Venture Technology, SP Manufacturing, and Tessolve Semiconductor. Novo Tellus also maintains previous investments in AEM Holdings, Novo Tellus Alpha Acquisition (SPAC), Luma Investments, Procurri, and MFS Technology. The firm's investment approach combines technology expertise, operating experience, and sector specialization to create lasting equity value for stakeholders.

Differentiator

Problem solved

Functional benefit

Products and services

• Novo Tellus Investment Services Private equity investment services focused on Southeast Asia's technology and industrials mid-market sector, providing patient growth capital, divisional carveout capital, management buyout financing, and strategic partnership to portfolio companies. The offering is delivered through managed investment funds, with the second Southeast Asia fund closed at $250 million in January 2021.

Quantifiable outcome

• Over 200% average value increase after investment since firm founding
• +4 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Olympus Capital Asia: Asia-focused mid-market PE firm with prior exposure across diversified sectors; relevant because Novo Tellus venture partner Vikram Beniwal was previously Managing Director there. Comparable Asia mid-market PE approach.
• ShawKwei & Partners: Singapore-based mid-market PE firm focused on Asian industrial and consumer companies. Comparable as a Singapore-based mid-market control investor; Novo Tellus Principal Pei Shan Wong previously worked there.
• Affirma Capital (formerly Standard Chartered PE): Southeast Asia-focused mid-market PE firm making control and growth investments in consumer, industrials, and technology. Directly comparable to Novo Tellus in geography, deal size, and sector breadth across Southeast Asia.
• Navis Capital Partners: Southeast Asia-focused control-buyout PE firm investing in mid-market companies across consumer, industrial, and services sectors. Comparable in geographic focus, fund size range, and control-buyout strategy.
• Creador: Southeast Asia-focused PE firm with multiple funds targeting growth and control investments in mid-market consumer and technology companies. Comparable regional mid-market PE strategy.

Broad incumbents

• ACTIS (Actis Asia): Emerging markets PE investor with significant Asia exposure, including infrastructure and growth investments. Comparable as a broader emerging-markets PE firm with Asia focus.
• Baring Private Equity Asia (EQT): Pan-Asia PE firm (now part of EQT) with broad sector exposure including technology, industrials, and services. Novo Tellus's Managing Partner previously worked at Baring PE Asia; comparable in Asia mid-market PE activity though significantly larger AUM.

Regional players

• Quadria Capital: Southeast Asia healthcare-focused PE firm. Comparable as a regional specialist mid-market PE manager pursuing control investments, though narrower in sector focus (healthcare).
• Northstar Group: Indonesia/Southeast Asia PE firm focused on control and growth investments in mid-market companies. Comparable geographically and in mid-market deal orientation.
• Clermont Partners: Singapore-based mid-market PE firm focused on Asia control buyouts. Comparable in regional mid-market control-buyout positioning though with broader sector exposure.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/novo-tellus-capital-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Investments8 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novo Tellus Capital Partners